Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Barohn

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical and Translational Science|May 9, 2017
Education and training of clinical and translational study investigators and research coordinators: A competency-based approachNancy A Calvin-Naylor, Carolynn Thomas Jones, Michelle M Wartak, et al.
Muscle & Nerve|November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosisSalman Bhai, Todd Levine, Dan Moore, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
The New England Journal of Medicine|August 3, 2007
Whole-genome analysis of sporadic amyotrophic lateral sclerosisTravis Dunckley, Matthew J Huentelman, David W Craig, et al.
Muscle & Nerve|July 22, 2014
Ataluren treatment of patients with nonsense mutation dystrophinopathyKatharine Bushby, Richard Finkel, Brenda Wong, et al.
Clinical and Translational Science|April 18, 2012
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS), Harry Shamoon, David Center, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2021
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, Martin R Turner, , et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical and Translational Science|May 9, 2017
Education and training of clinical and translational study investigators and research coordinators: A competency-based approachNancy A Calvin-Naylor, Carolynn Thomas Jones, Michelle M Wartak, et al.
Muscle & Nerve|November 8, 2024
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosisSalman Bhai, Todd Levine, Dan Moore, et al.
Muscle & Nerve|June 3, 2020
Clinical features of LRP4/agrin-antibody-positive myasthenia gravis: A multicenter studyMichael H Rivner, Brandy M Quarles, Jin-Xiu Pan, et al.
The New England Journal of Medicine|August 3, 2007
Whole-genome analysis of sporadic amyotrophic lateral sclerosisTravis Dunckley, Matthew J Huentelman, David W Craig, et al.
Muscle & Nerve|July 22, 2014
Ataluren treatment of patients with nonsense mutation dystrophinopathyKatharine Bushby, Richard Finkel, Brenda Wong, et al.
Clinical and Translational Science|April 18, 2012
Preparedness of the CTSA's structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS), Harry Shamoon, David Center, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 19, 2021
Preface: promoting research in PLS: current knowledge and future challengesHiroshi Mitsumoto, Martin R Turner, , et al.
JAMA Neurology|February 18, 2020
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical TrialJames F Howard, Richard J Nowak, Gil I Wolfe, et al.
Muscle & Nerve|December 15, 2015
Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridineTed M Burns, Gordon A Smith, Jeffrey A Allen, et al.
Pageof 4